ESR1 and breast cancer: These results are similar to what was seen in ER+ breast cancer cells expressing short hairpin RNA (shRNA) sequences against MCL1 (shMcl1) (Figure 4F), which displayed increased Caspase3/7 activity as compared to cells expressing non-targeting control sequences (shControl) (Figure 4G).